ASH Consultative Hematology Course Schedule and Program
September 9, 2021
The ASH Consultative Hematology Course (CHC) is a virtual half-day program led by faculty familiar with consultative practice issues and commonly encountered clinical problems that require the expertise of a hematologist. Program participants engage in case-based presentations and have the opportunity to interact with experts during the live Q&A panel. The 2021 program features discussions on non-malignant hematology topics, such as inherited bone marrow disorders, sickle cell disease, microangiopathies, and rare bleeding disorders.
- Jeffrey M. Lipton, MD, PhD, Northwell Health
- Anaadriana Zakarija, MD, Northwestern University
Thursday, September 9
|2:00 p.m.||Welcome and Opening Remarks|
|2:10 p.m.||Inherited Bone Marrow Disorders|
||Diagnosis of Rare Bleeding Disorders|
||New Sickle Cell Disease Therapies and Transitions to Adult Care|
||Hemophagocytic Lymphohistiocytosis (HLH)|
||DOAC Reversal and Heavy Menstrual Bleeding|
||Antiphospholipid Antibody Syndromes (APS)|
|5:00 p.m.||Live Q&A Panel with All Speakers & Closing Remarks|
*All sessions are listed in Eastern time. Session topics and speakers are subject to change and speakers will be updated upon final approval by the American Society of Hematology.
- ASH Meeting on Hematologic Malignancies
The 2021 meeting will be offered in-person and is also available online as a virtual meeting for those unable to participate in person.
- CME and MOC Information for ASH Meetings
Learn about and attain continuing medical education (CME), maintenance of certification (MOC), and certificates of attendance for ASH meetings.